Biocon in very unique position globally as a biosimilars leader: Kiran Mazumdar-Shaw
Biocon holds a distinctive global position as a leader in biosimilars, said Kiran Mazumdar-Shaw, Executive Chairperson. She highlighted the company’s strong pipeline, innovation capabilities, and strategic partnerships, enabling it to deliver affordable biologics worldwide. Biocon’s focus on research, quality, and scalable manufacturing continues to strengthen its leadership in the competitive global biosimilars market.